[Hemophagocytic syndrome associated with cytomegalovirus viral infection].
The clinical case of a 19-year old woman with the clinical criteria of Cytomegalovirus (CMV) viral associated with Hemophagocytic syndrome (VAHS) is presented. The clinical outcome was poor and rapidly progressive, ending in exitus letalis. The principal concepts and characteristics of the Hemophagocytic syndrome are discussed, stressing the current consensus rules and the variations in management according to international guidelines.
Núñez Bacarreza
J J
JJ
Unidad de Terapia Intensiva, Hospital Ángeles México, Distrito Federal, México. juanjosenuba@hotmail.com
Montiel López
L
L
Núñez del Prado Alcoreza
J R
JR
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000097:blood; D003131:Combined Modality Therapy; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000175:diagnosis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D017707:Erythrocyte Transfusion; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D012121:Respiration, Artificial; D012307:Risk Factors; D012772:Shock, Septic / Q000209:etiology; D017180:Tachycardia, Ventricular / Q000209:etiology; D055815:Young Adult
D000305:Adrenal Cortex Hormones; D000890:Anti-Infective Agents; D000914:Antibodies, Viral; D016756:Immunoglobulins, Intravenous